RACGP Position statement: Medicinal use of cannabis products
Recent changes to legislation around medical cannabis and media coverage has created a perception of easy access to cannabis products. General practitioners may now experience greater patient demand to prescribe cannabis-based medications.
To address this, the RACGP has developed a position statement that outlines our position on prescribing medicinal cannabis products in general practice, the challenges GPs face, the current evidence and legal framework in Australia.
The current evidence-base for the use of cannabis-based medicines is still emerging, and the products can be prescribed under strict protocols. As for all medications, cannabis products must be approved or registered through the Therapeutic Goods Administration (TGA) before they can be prescribed.